Rezolute announces initiation of a phase 2 study of rz402 in patients with diabetic macular edema

Rz402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye rz402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye

RZLT Ratings Summary

RZLT Quant Ranking